Cognition, Iron Deficiency, Iron Deficiency Anemia
Conditions
Keywords
Food Fortification, Iron deficiency, NaFeEdta, Iron deficiency anemia, Cognition
Brief summary
This study is designed to evaluate the efficacy of NaFeEDTA-fortified whole wheat flour in improving cognition, hemoglobin, iron status and total body iron among school children in urban Bangalore.
Detailed description
Background: Iron (Fe) deficiency is a major cause of anemia in children. Fortification of wheat flour with NaFeEDTA, a highly bioavailable iron fortificant that protects Fe from the phytic acid present in wheat flour, could be a practical approach to addressing this problem. Aims: To evaluate the efficacy of NaFeEDTA-fortified whole wheat flour in improving mental performance and reducing iron deficiency and improving body iron stores in urban, school going Indian children. Methods: A randomized, double-blind, 7 month, school-based feeding trial was carried out in Bangalore, India. Iron-depleted (serum ferritin, SF \<20 µg/L), and/or iron deficient (serum transferrin receptor, TfR \>7.6 mg/L), 6 -13 year old children (N=194) were randomly assigned to either receive a whole wheat flour based lunch meal fortified with 6 mg Fe as NaFeEDTA or an identical unfortified control meal. The meals were administered under supervision and left overs were weighed. Hemoglobin (Hb) and iron status were measured at baseline, 3.5 months, and 7 months. At baseline and at 7 months, the study children were also subjected to a battery of cognitive tests to assess attention/concentration, motor development, visuospatial and verbal abilities. Sensory evaluation using triangle tests were carried out using meals prepared from the fortified and unfortified whole wheat flour.
Interventions
NaFeEdta Fortified Wheat Flour (100g)provided as a lunch meal. Fortification level of 6mg Fe/100g/day/child for 7 months
Sponsors
Study design
Eligibility
Inclusion criteria
* Children with depleted iron stores (serum ferritin \< 20 µg/L or iron deficiency serum transferrin receptor \>7.6 mg/L)
Exclusion criteria
* Hb \< 8g/dl, any metabolic illness, use of medication, on iron supplementation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change in cognitive abilities | 7 months |
Secondary
| Measure | Time frame |
|---|---|
| changes in iron status indicators | 7 months |
Countries
India